Li, Hao http://orcid.org/0000-0001-9426-9446
Sun, Zewen
Xiao, Rongxin http://orcid.org/0000-0002-0880-093X
Qi, Qingyi
Li, Xiao http://orcid.org/0000-0002-0455-0355
Huang, Haiyan
Wang, Xuan
Zhou, Jian
Wang, Zhenfan
Liu, Ke
Yin, Ping
Yang, Fan
Wang, Jun http://orcid.org/0000-0002-7033-5012
Funding for this research was provided by:
National Natural Science Foundation of China (82002410, 92059203)
Peking University People’s Hospital Scientific Research Development Funds
Article History
Received: 2 November 2021
Revised: 25 March 2022
Accepted: 4 April 2022
First Online: 26 May 2022
Competing interests
: HH and KL were employed by the company Berry Oncology, Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This study was approved by the Institutional Review Board at Peking University People’s Hospital (2020PHB363-01). The study was performed in accordance with the Declaration of Helsinki.
: No individual person’s data is presented in this manuscript.